Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
18.50
0.00 (0.00%)
At close: Oct 23, 2025
TEVJF Market Cap
TEVJF has a market cap or net worth of $23.21 billion as of October 30, 2025. Its market cap has increased by 18.81% in one year.
Market Cap
23.21B
Enterprise Value
38.59B
Revenue
16.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
$18.50
Market Cap Chart
Since June 26, 1992, TEVJF's market cap has increased from 588.88M to 23.21B, an increase of 3,840.82%. That is a compound annual growth rate of 11.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 23.21B | -7.20% |
| Dec 31, 2024 | 25.01B | 113.68% |
| Dec 29, 2023 | 11.70B | 15.54% |
| Dec 30, 2022 | 10.13B | 14.65% |
| Dec 31, 2021 | 8.84B | -16.46% |
| Dec 31, 2020 | 10.58B | -1.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 648.67M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 355.88M |
| Silence Therapeutics | 341.50M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 303.60M |
| American Oncology Network | 297.14M |